Evidence map›Paper›PMID 42265881›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2026

Patterns of miRNA Expression in Primary and Metastatic Wilms Tumor.

Ádám Csók, Tamás Micsik, Zsófia Magyar, Tamás Tornóczky, Levente Kuthi, Alexandra Barbara Kabai, Krisztina Szirák, Melinda Szilágyi, Monika Csóka, Gábor Ottóffy and 3 more

Abstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ádám CsókDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Tamás MicsikDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Zsófia MagyarDepartment of Obstetrics and Gynaecology, Baross Street Division, Semmelweis University, Budapest, Hungary.
Tamás TornóczkyDepartment of Pathology, University of Pécs Medical School and Clinical Center, Pécs, Hungary.
Levente KuthiDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.ORCID 0000-0001-9247-6679
Alexandra Barbara KabaiDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Krisztina SzirákDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Melinda SzilágyiDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Monika CsókaDepartment of Paediatrics, Semmelweis University, Budapest, Hungary.
Gábor OttóffyDepartment of Pediatrics, University of Pécs Medical School and Clinical Center, Pécs, Hungary.
Beáta SoltészDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
István BaloghDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Gergely BuglyóDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Wilms tumor (WT) development and the ability to form distant metastases are thought to be governed by a wide range of molecular factors, with prominent involvement of microRNAs (miRNAs). However, very few studies have explored alterations in miRNA expression between primary and metastatic WT, and all of them focused on a narrow set of miRNAs. MATERIAL AND METHODS We investigated miRNA expression in primary (10) and metastatic WT (6) and in healthy kidney specimens (10) using formalin-fixed, paraffin-embedded (FFPE) samples. miRNA was extracted from FFPE samples using miRNeasy FFPE Kits by Qiagen. Following reverse transcription, cDNA was amplified using miRCURY LNA miRNA Focus PCR Panels by Qiagen, which included primers against 84 specific miRNA targets, of which 81 were successfully amplified. Expression in metastatic WT was compared with primary tumors and healthy kidney tissue. RESULTS Differential expression was particularly evident for 5 miRNAs (miR-17-3p, miR-34b-3p, miR-34c-5p, miR-375-3p, miR-616-3p). Our findings regarding the miR-34 family seem noteworthy in light of the limited existing literature, which similarly reports elevated expression of these miRNAs in WT, although they are more commonly downregulated in many other cancer types. CONCLUSIONS While the sample size in this study was modest, our findings suggest that metastatic tumors exhibit distinct miRNA expression patterns, which may have value for identifying tumors at risk of metastasis. We encourage further studies to validate or refute the role of the miRNAs proposed here in the development of metastasis.

Indexed as

Gene Expression Regulation, NeoplasticKidney NeoplasmsMicroRNAsWilms TumorFemaleGene Expression ProfilingHumansNeoplasm MetastasisParaffin EmbeddingMicroRNAsMIRN34 microRNA, human

Identifiers

PMID42265881
PMCPMC13267525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.